CG
ALDR

Cutler Group’s Alder Biopharmaceuticals ALDR Stock Holding History

Cutler Group’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,500
Closed -$28K – 4974
2019
Q3 		$28K Buy
+1,500
New +$17.2K ﹤0.01% 1954
2018
Q2 		– Sell
-1,160
Closed -$14K – 5246
2018
Q1 		$14K Sell
1,160
-8,541
-88% -$124K ﹤0.01% 2564
2017
Q4 		$111K Sell
9,701
-6,324
-39% -$70.6K ﹤0.01% 1313
2017
Q3 		$196K Sell
16,025
-26,945
-63% -$281K 0.01% 1193
2017
Q2 		$492K Buy
42,970
+36,089
+524% +$667K 0.02% 702
2017
Q1 		$143K Sell
6,881
-6,002
-47% -$133K 0.01% 1442
2016
Q4 		$267K Buy
12,883
+7,811
+154% +$203K 0.01% 1097
2016
Q3 		$166K Sell
5,072
-3,019
-37% -$91.9K 0.01% 1384
2016
Q2 		$202K Buy
8,091
+1,743
+27% +$47.2K 0.01% 1118
2016
Q1 		$155K Buy
6,348
+915
+17% +$21.2K 0.01% 1205
2015
Q4 		$179K Buy
+5,433
New +$184K 0.01% 1276

Cutler Group's ALDR Position: Q4 2019 in Review

Cutler Group sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 1,500 shares — an estimated $28K sold.

Cutler Group first reported a position in ALDR in Q4 2015 and held it in 11 quarters. The position peaked at $492K in Q2 2017. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Cutler Group reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Cutler Group sold 1,500 Alder Biopharmaceuticals shares in Q4 2019, an estimated $28K.
  • Cutler Group first reported a position in Alder Biopharmaceuticals in Q4 2015 and held it in 11 quarters.
  • Cutler Group's Alder Biopharmaceuticals position peaked at $492K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Cutler Group's 13F filing for Q4 2019, filed 6 Feb 2020.